Philip H Coelho - Insider Trading Tracker

Ampio Pharmaceuticals, Inc.

US ˙ OTCPK ˙ US03209T1097

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Philip H Coelho. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Philip H Coelho telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:CPRX / Catalyst Pharmaceuticals, Inc.	Director	204,887
US:AMPE / Ampio Pharmaceuticals, Inc.	Director	75,000
US:MEDW / Mediware Information Systems Inc	Director	0

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Philip H Coelho. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam AMPE / Ampio Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam AMPE / Ampio Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2017-09-27	AMPE	COELHO PHILIP H	10,000	0.6270	571	10.9725	6,270	92	83.8	41,580	663.15
2017-09-22	AMPE	COELHO PHILIP H	3,000	0.6000	171	10.5000	1,800
2017-09-20	AMPE	COELHO PHILIP H	1,000	0.5918	57	10.3565	592
2017-09-19	AMPE	COELHO PHILIP H	15,000	0.5679	857	9.9382	8,518
2017-09-05	AMPE	COELHO PHILIP H	30,000	0.5592	1,714	9.7860	16,776

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam AMPE / Ampio Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam AMPE / Ampio Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2021-05-21 AMPE COELHO PHILIP H 6,737 2.0000 385 35.0000 13,474 362 3.602 -12,091 -89.73

2021-04-29 AMPE COELHO PHILIP H 3,263 2.0000 186 35.0000 6,526

2021-04-27 AMPE COELHO PHILIP H 20,000 2.0000 1,143 35.0000 40,000

2013-11-18 AMPE COELHO PHILIP H 13,287 8.2536 759 144.4380 109,666

2013-11-15 AMPE COELHO PHILIP H 11,320 8.2217 647 143.8798 93,070

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam CPRX / Catalyst Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam AMPE / Ampio Pharmaceuticals, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2016-06-17 CPRX COELHO PHILIP H 1,700 0.7500 1,700 0.7500 1,275 357 2.3900 2,788 218.67

2016-06-17 CPRX COELHO PHILIP H 13,300 0.7600 13,300 0.7600 10,108

2016-03-17 CPRX COELHO PHILIP H 10,000 1.0600 10,000 1.0600 10,600

2012-11-15 CPRX COELHO PHILIP H 24,000 0.4107 24,000 0.4107 9,857

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam CPRX / Catalyst Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam AMPE / Ampio Pharmaceuticals, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2022-11-23 CPRX COELHO PHILIP H 9,999 17.4500 9,999 17.4500 174,483 184 11.5000 -59,494 -34.10

2022-11-22 CPRX COELHO PHILIP H 20,001 17.3040 20,001 17.3040 346,097

2022-11-21 CPRX COELHO PHILIP H 70,000 15.2310 70,000 15.2310 1,066,170

2022-09-14 CPRX COELHO PHILIP H 20,000 15.7500 20,000 15.7500 315,000

2022-09-13 CPRX COELHO PHILIP H 10,000 15.7000 10,000 15.7000 157,000

2021-08-26 CPRX COELHO PHILIP H 9,044 5.4500 9,044 5.4500 49,290

2021-08-26 CPRX COELHO PHILIP H 504 5.4600 504 5.4600 2,752

2021-08-25 CPRX COELHO PHILIP H 9,498 5.5600 9,498 5.5600 52,809

2021-08-24 CPRX COELHO PHILIP H 9,494 5.5750 9,494 5.5750 52,929

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Philip H Coelho seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2023-05-05 2023-05-04 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 50,000 204,887 32.28 0.79 39,500 161,861

2023-02-17 2023-02-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 4,000 154,887 2.65

2022-12-08 2022-12-06 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 1,334 150,887 0.89

2022-11-23 2022-11-23 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -9,999 149,553 -6.27 17.45 -174,483 2,609,700

2022-11-23 2022-11-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -20,001 159,552 -11.14 17.30 -346,097 2,760,888

2022-11-23 2022-11-21 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -70,000 179,553 -28.05 15.23 -1,066,170 2,734,772

2022-09-15 2022-09-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -20,000 249,553 -7.42 15.75 -315,000 3,930,460

2022-09-15 2022-09-13 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -10,000 269,553 -3.58 15.70 -157,000 4,231,982

2022-08-19 2022-08-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 40,000 279,553 16.70 2.53 101,200 707,269

2022-02-16 2022-02-14 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units A - Award 12,000 336,834 3.69

2022-01-03 2021-12-30 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 75,000 75,000

2021-12-30 2021-12-28 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 20,000 324,834 6.56

2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units A - Award -1,333 304,834 -0.44

2021-12-06 2021-12-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common Stock, par value $0.001 per share M - Exercise 1,333 239,553 0.56

2021-10-15 2021-10-13 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 120,000 120,000

2021-08-26 2021-08-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock M - Exercise -16,666 306,167 -5.16

2021-08-26 2021-08-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -504 238,220 -0.21 5.46 -2,752 1,300,681

2021-08-26 2021-08-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -9,044 238,724 -3.65 5.45 -49,290 1,301,046

2021-08-26 2021-08-26 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 16,666 247,768 7.21 3.12 51,998 773,036

2021-08-26 2021-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock M - Exercise -16,667 322,833 -4.91

2021-08-26 2021-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -9,498 231,102 -3.95 5.56 -52,809 1,284,927

2021-08-26 2021-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 16,667 240,600 7.44 3.12 52,001 750,672

2021-08-26 2021-08-24 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock M - Exercise -16,667 339,500 -4.68

2021-08-26 2021-08-24 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share S - Sale -9,494 223,933 -4.07 5.58 -52,929 1,248,426

2021-08-26 2021-08-24 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 16,667 233,427 7.69 3.12 52,001 728,292

2021-05-25 2021-05-21 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) M - Exercise -6,737 0 -100.00

2021-05-25 2021-05-21 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock S - Sale -6,737 203,500 -3.20 2.00 -13,474 407,000

2021-05-25 2021-05-21 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock M - Exercise X 6,737 210,237 3.31 0.40 2,695 84,095

2021-04-29 2021-04-29 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) M - Exercise X -3,263 6,737 -32.63 0.40 -1,305 2,695

2021-04-29 2021-04-29 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock S - Sale -3,263 203,500 -1.58 2.00 -6,526 407,000

2021-04-29 2021-04-29 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock M - Exercise X 3,263 206,763 1.60 0.40 1,305 82,705

2021-04-29 2021-04-27 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) M - Exercise X -20,000 10,000 -66.67 0.40 -8,000 4,000

2021-04-29 2021-04-27 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock S - Sale -20,000 203,500 -8.95 2.00 -40,000 407,000

2021-04-29 2021-04-27 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock M - Exercise X 20,000 223,500 9.83 0.40 8,000 89,400

2021-01-05 2021-01-04 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 13,513 203,500 7.11 1.48 19,999 301,180

2021-01-04 2020-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 30,000 356,167 9.20

2020-12-23 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units A - Award -1,333 326,167 -0.41

2020-12-23 2020-12-22 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 1,333 216,760 0.62

2020-12-15 2020-12-12 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 36,000 36,000

2020-07-06 2020-07-01 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 136,471 136,471

2020-07-06 2020-07-01 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -160,554 0 -100.00

2020-01-06 2020-01-02 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 34,059 189,987 21.84 0.59 19,999 111,560

2019-12-23 2019-12-19 4 AMPE Ampio Pharmaceuticals, Inc.
Option (Right to Buy) A - Award 36,000 36,000

2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Restricted Stock Units A - Award 4,000 327,500 1.24

2019-12-04 2019-12-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 33,500 323,500 11.55

2019-09-11 2019-09-09 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 369,750 0 -100.00

2019-09-11 2015-12-12 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -30,000 0 -100.00

2019-09-11 2014-12-20 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -50,000 0 -100.00

2019-09-11 2012-05-07 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -75,000 0 -100.00

2019-09-11 2012-05-07 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -100,000 0 -100.00

2019-09-11 2011-03-31 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -150,000 0 -100.00

2019-09-11 2010-08-27 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) D - Sale to Issuer -30,000 0 -100.00

2019-01-09 2018-12-15 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 30,000 30,000

2019-01-04 2019-01-02 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 45,454 155,928 41.14 0.44 20,000 68,608

2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 25,000 290,000 9.43

2018-12-21 2018-12-19 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 25,000 290,000 9.43

2018-01-29 2018-01-25 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 5,747 110,474 5.49 3.48 20,000 384,450

2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 20,000 240,000 9.09

2018-01-04 2018-01-02 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 20,000 240,000 9.09

2017-11-13 2017-11-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock M - Exercise -50,000 145,000 -25.64

2017-11-13 2017-11-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share F - Taxes -7,860 215,427 -3.52

2017-11-13 2017-11-09 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 50,000 223,287 28.85 0.47 23,500 104,945

2017-09-28 2017-09-27 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase 10,000 104,727 10.56 0.63 6,270 65,664

2017-09-28 2017-09-23 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 30,000 30,000

2017-09-22 2017-09-22 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase 3,000 94,727 3.27 0.60 1,800 56,836

2017-09-22 2017-09-20 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase 1,000 91,727 1.10 0.59 592 54,284

2017-09-21 2017-09-19 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase 15,000 90,727 19.81 0.57 8,518 51,524

2017-09-07 2017-09-05 4/A AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase 30,000 75,727 65.61 0.56 16,776 42,347

2017-09-06 2017-09-05 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock P - Purchase -30,000 75,727 -28.37 0.56 -16,776 42,347

2017-01-09 2017-01-07 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 30,000 30,000

2017-01-05 2017-01-03 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 20,826 45,727 83.64 0.96 19,999 43,912

2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 30,000 250,000 13.64

2017-01-05 2017-01-03 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 30,000 250,000 13.64

2016-06-20 2016-06-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share P - Purchase 13,300 173,287 8.31 0.76 10,108 131,698

2016-06-20 2016-06-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share P - Purchase 1,700 159,987 1.07 0.75 1,275 119,990

2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 25,000 215,000 13.16

2016-06-17 2016-06-15 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 25,000 215,000 13.16

2016-03-17 2016-03-17 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share P - Purchase 10,000 158,287 6.74 1.06 10,600 167,784

2016-01-06 2016-01-04 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 6,042 24,901 32.04 3.31 19,999 82,422

2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 20,000 165,000 13.79

2016-01-04 2015-12-30 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock A - Award 20,000 165,000 13.79

2015-12-15 2015-12-12 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (Right to Buy) A - Award 30,000 30,000

2015-08-26 2015-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Options to purchase common stock M - Exercise -25,000 125,000 -16.67

2015-08-26 2015-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share F - Taxes -8,385 148,287 -5.35

2015-08-26 2015-08-25 4 CPRX CATALYST PHARMACEUTICALS, INC.
Common stock, par value $0.001 per share M - Exercise 16,615 156,672 11.86 1.09 18,110 170,772

2015-01-06 2015-01-02 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 2,666 18,859 16.46 3.75 9,998 70,721

2014-12-29 2014-12-20 4/A AMPE Ampio Pharmaceuticals, Inc.
Stock Option (right to buy) A - Award 50,000 50,000

2014-12-23 2014-12-20 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (right to buy) A - Award -50,000 50,000 -50.00

2014-10-06 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock M - Exercise -30,000 150,000 -16.67

2014-10-06 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share F - Taxes -9,964 131,672 -7.03

2014-10-06 2014-10-02 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common stock, par value $0.001 per share M - Exercise 20,036 141,636 16.48 0.90 18,032 127,472

2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock A - Award 25,000 180,000 16.13

2014-09-02 2014-08-28 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock A - Award 25,000 180,000 16.13

2014-01-06 2014-01-02 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 1,403 16,193 9.49 7.13 10,003 115,456

2013-11-20 2013-11-18 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock S - Sale -13,287 14,790 -47.32 8.25 -109,666 122,071

2013-11-20 2013-11-15 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock S - Sale -11,320 28,077 -28.73 8.22 -93,070 230,841

2013-01-04 2013-01-02 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 2,584 39,397 7.02 3.87 10,000 152,466

2012-12-14 2012-12-12 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Options to purchase common stock A - Award 50,000 145,000 52.63

2012-11-19 2012-11-15 4 CPRX CATALYST PHARMACEUTICAL PARTNERS, INC.
Common Stock, par value $0.001 per share P - Purchase 24,000 24,000 0.41 9,857 9,857

2012-11-13 2012-11-09 4 MEDW MEDIWARE INFORMATION SYSTEMS INC
Common Stock D - Sale to Issuer -1,014 0 -100.00 22.00 -22,308

2012-05-09 2012-05-07 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (right to buy) A - Award 75,000 75,000

2012-05-09 2012-05-07 4 AMPE Ampio Pharmaceuticals, Inc.
Stock Option (right to buy) A - Award 100,000 100,000

2012-02-13 2012-02-09 4 MEDW MEDIWARE INFORMATION SYSTEMS INC
Common Stock, par value $.10 S - Sale -7,380 1,014 -87.92 13.55 -99,999 13,740

2012-01-17 2012-01-13 4 AMPE Ampio Pharmaceuticals, Inc.
Common Stock A - Award 2,268 36,813 6.57 4.41 10,002 162,345

2012-01-04 2012-01-03 4 MEDW MEDIWARE INFORMATION SYSTEMS INC
Common Stock, par value $.10 A - Award 785 8,394 10.32

2011-09-27 3 AMPE Ampio Pharmaceuticals, Inc.
Common Stock 4,545

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2021-05-21	AMPE	COELHO PHILIP H	6,737	2.0000	385	35.0000	13,474	362	3.602	-12,091	-89.73
2021-04-29	AMPE	COELHO PHILIP H	3,263	2.0000	186	35.0000	6,526
2021-04-27	AMPE	COELHO PHILIP H	20,000	2.0000	1,143	35.0000	40,000
2013-11-18	AMPE	COELHO PHILIP H	13,287	8.2536	759	144.4380	109,666
2013-11-15	AMPE	COELHO PHILIP H	11,320	8.2217	647	143.8798	93,070

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2016-06-17	CPRX	COELHO PHILIP H	1,700	0.7500	1,700	0.7500	1,275	357	2.3900	2,788	218.67
2016-06-17	CPRX	COELHO PHILIP H	13,300	0.7600	13,300	0.7600	10,108
2016-03-17	CPRX	COELHO PHILIP H	10,000	1.0600	10,000	1.0600	10,600
2012-11-15	CPRX	COELHO PHILIP H	24,000	0.4107	24,000	0.4107	9,857

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2022-11-23	CPRX	COELHO PHILIP H	9,999	17.4500	9,999	17.4500	174,483	184	11.5000	-59,494	-34.10
2022-11-22	CPRX	COELHO PHILIP H	20,001	17.3040	20,001	17.3040	346,097
2022-11-21	CPRX	COELHO PHILIP H	70,000	15.2310	70,000	15.2310	1,066,170
2022-09-14	CPRX	COELHO PHILIP H	20,000	15.7500	20,000	15.7500	315,000
2022-09-13	CPRX	COELHO PHILIP H	10,000	15.7000	10,000	15.7000	157,000
2021-08-26	CPRX	COELHO PHILIP H	9,044	5.4500	9,044	5.4500	49,290
2021-08-26	CPRX	COELHO PHILIP H	504	5.4600	504	5.4600	2,752
2021-08-25	CPRX	COELHO PHILIP H	9,498	5.5600	9,498	5.5600	52,809
2021-08-24	CPRX	COELHO PHILIP H	9,494	5.5750	9,494	5.5750	52,929

Tarikh Fail	Tarikh Tran	Borang	Simbol Saham	Sekuriti	Kod	10b5-1	Saham	Baki Saham	Peratus Ubah	Saham harga	Tran Nilai	Baki Nilai
2023-05-05	2023-05-04	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		50,000	204,887	32.28	0.79	39,500	161,861
2023-02-17	2023-02-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		4,000	154,887	2.65
2022-12-08	2022-12-06	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		1,334	150,887	0.89
2022-11-23	2022-11-23	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-9,999	149,553	-6.27	17.45	-174,483	2,609,700
2022-11-23	2022-11-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-20,001	159,552	-11.14	17.30	-346,097	2,760,888
2022-11-23	2022-11-21	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-70,000	179,553	-28.05	15.23	-1,066,170	2,734,772
2022-09-15	2022-09-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-20,000	249,553	-7.42	15.75	-315,000	3,930,460
2022-09-15	2022-09-13	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-10,000	269,553	-3.58	15.70	-157,000	4,231,982
2022-08-19	2022-08-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		40,000	279,553	16.70	2.53	101,200	707,269
2022-02-16	2022-02-14	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award		12,000	336,834	3.69
2022-01-03	2021-12-30	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		75,000	75,000
2021-12-30	2021-12-28	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		20,000	324,834	6.56
2021-12-06	2021-12-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award		-1,333	304,834	-0.44
2021-12-06	2021-12-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share	M - Exercise		1,333	239,553	0.56
2021-10-15	2021-10-13	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		120,000	120,000
2021-08-26	2021-08-26	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise		-16,666	306,167	-5.16
2021-08-26	2021-08-26	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-504	238,220	-0.21	5.46	-2,752	1,300,681
2021-08-26	2021-08-26	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-9,044	238,724	-3.65	5.45	-49,290	1,301,046
2021-08-26	2021-08-26	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		16,666	247,768	7.21	3.12	51,998	773,036
2021-08-26	2021-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise		-16,667	322,833	-4.91
2021-08-26	2021-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-9,498	231,102	-3.95	5.56	-52,809	1,284,927
2021-08-26	2021-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		16,667	240,600	7.44	3.12	52,001	750,672
2021-08-26	2021-08-24	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise		-16,667	339,500	-4.68
2021-08-26	2021-08-24	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	S - Sale		-9,494	223,933	-4.07	5.58	-52,929	1,248,426
2021-08-26	2021-08-24	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		16,667	233,427	7.69	3.12	52,001	728,292
2021-05-25	2021-05-21	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	M - Exercise		-6,737	0	-100.00
2021-05-25	2021-05-21	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	S - Sale		-6,737	203,500	-3.20	2.00	-13,474	407,000
2021-05-25	2021-05-21	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	M - Exercise	X	6,737	210,237	3.31	0.40	2,695	84,095
2021-04-29	2021-04-29	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	M - Exercise	X	-3,263	6,737	-32.63	0.40	-1,305	2,695
2021-04-29	2021-04-29	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	S - Sale		-3,263	203,500	-1.58	2.00	-6,526	407,000
2021-04-29	2021-04-29	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	M - Exercise	X	3,263	206,763	1.60	0.40	1,305	82,705
2021-04-29	2021-04-27	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	M - Exercise	X	-20,000	10,000	-66.67	0.40	-8,000	4,000
2021-04-29	2021-04-27	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	S - Sale		-20,000	203,500	-8.95	2.00	-40,000	407,000
2021-04-29	2021-04-27	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	M - Exercise	X	20,000	223,500	9.83	0.40	8,000	89,400
2021-01-05	2021-01-04	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		13,513	203,500	7.11	1.48	19,999	301,180
2021-01-04	2020-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		30,000	356,167	9.20
2020-12-23	2020-12-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award		-1,333	326,167	-0.41
2020-12-23	2020-12-22	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		1,333	216,760	0.62
2020-12-15	2020-12-12	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		36,000	36,000
2020-07-06	2020-07-01	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		136,471	136,471
2020-07-06	2020-07-01	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-160,554	0	-100.00
2020-01-06	2020-01-02	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		34,059	189,987	21.84	0.59	19,999	111,560
2019-12-23	2019-12-19	4	AMPE	Ampio Pharmaceuticals, Inc. Option (Right to Buy)	A - Award		36,000	36,000
2019-12-04	2019-12-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Restricted Stock Units	A - Award		4,000	327,500	1.24
2019-12-04	2019-12-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		33,500	323,500	11.55
2019-09-11	2019-09-09	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		369,750	0	-100.00
2019-09-11	2015-12-12	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-30,000	0	-100.00
2019-09-11	2014-12-20	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-50,000	0	-100.00
2019-09-11	2012-05-07	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-75,000	0	-100.00
2019-09-11	2012-05-07	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-100,000	0	-100.00
2019-09-11	2011-03-31	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-150,000	0	-100.00
2019-09-11	2010-08-27	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		-30,000	0	-100.00
2019-01-09	2018-12-15	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		30,000	30,000
2019-01-04	2019-01-02	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		45,454	155,928	41.14	0.44	20,000	68,608
2018-12-21	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		25,000	290,000	9.43
2018-12-21	2018-12-19	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		25,000	290,000	9.43
2018-01-29	2018-01-25	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		5,747	110,474	5.49	3.48	20,000	384,450
2018-01-04	2018-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		20,000	240,000	9.09
2018-01-04	2018-01-02	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		20,000	240,000	9.09
2017-11-13	2017-11-09	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise		-50,000	145,000	-25.64
2017-11-13	2017-11-09	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	F - Taxes		-7,860	215,427	-3.52
2017-11-13	2017-11-09	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		50,000	223,287	28.85	0.47	23,500	104,945
2017-09-28	2017-09-27	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		10,000	104,727	10.56	0.63	6,270	65,664
2017-09-28	2017-09-23	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		30,000	30,000
2017-09-22	2017-09-22	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		3,000	94,727	3.27	0.60	1,800	56,836
2017-09-22	2017-09-20	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		1,000	91,727	1.10	0.59	592	54,284
2017-09-21	2017-09-19	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		15,000	90,727	19.81	0.57	8,518	51,524
2017-09-07	2017-09-05	4/A	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		30,000	75,727	65.61	0.56	16,776	42,347
2017-09-06	2017-09-05	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	P - Purchase		-30,000	75,727	-28.37	0.56	-16,776	42,347
2017-01-09	2017-01-07	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		30,000	30,000
2017-01-05	2017-01-03	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		20,826	45,727	83.64	0.96	19,999	43,912
2017-01-05	2017-01-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		30,000	250,000	13.64
2017-01-05	2017-01-03	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		30,000	250,000	13.64
2016-06-20	2016-06-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase		13,300	173,287	8.31	0.76	10,108	131,698
2016-06-20	2016-06-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase		1,700	159,987	1.07	0.75	1,275	119,990
2016-06-17	2016-06-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		25,000	215,000	13.16
2016-06-17	2016-06-15	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		25,000	215,000	13.16
2016-03-17	2016-03-17	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	P - Purchase		10,000	158,287	6.74	1.06	10,600	167,784
2016-01-06	2016-01-04	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		6,042	24,901	32.04	3.31	19,999	82,422
2016-01-04	2015-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		20,000	165,000	13.79
2016-01-04	2015-12-30	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	A - Award		20,000	165,000	13.79
2015-12-15	2015-12-12	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (Right to Buy)	A - Award		30,000	30,000
2015-08-26	2015-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Options to purchase common stock	M - Exercise		-25,000	125,000	-16.67
2015-08-26	2015-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	F - Taxes		-8,385	148,287	-5.35
2015-08-26	2015-08-25	4	CPRX	CATALYST PHARMACEUTICALS, INC. Common stock, par value $0.001 per share	M - Exercise		16,615	156,672	11.86	1.09	18,110	170,772
2015-01-06	2015-01-02	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		2,666	18,859	16.46	3.75	9,998	70,721
2014-12-29	2014-12-20	4/A	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (right to buy)	A - Award		50,000	50,000
2014-12-23	2014-12-20	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (right to buy)	A - Award		-50,000	50,000	-50.00
2014-10-06	2014-10-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	M - Exercise		-30,000	150,000	-16.67
2014-10-06	2014-10-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	F - Taxes		-9,964	131,672	-7.03
2014-10-06	2014-10-02	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common stock, par value $0.001 per share	M - Exercise		20,036	141,636	16.48	0.90	18,032	127,472
2014-09-02	2014-08-28	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award		25,000	180,000	16.13
2014-09-02	2014-08-28	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award		25,000	180,000	16.13
2014-01-06	2014-01-02	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		1,403	16,193	9.49	7.13	10,003	115,456
2013-11-20	2013-11-18	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	S - Sale		-13,287	14,790	-47.32	8.25	-109,666	122,071
2013-11-20	2013-11-15	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	S - Sale		-11,320	28,077	-28.73	8.22	-93,070	230,841
2013-01-04	2013-01-02	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		2,584	39,397	7.02	3.87	10,000	152,466
2012-12-14	2012-12-12	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Options to purchase common stock	A - Award		50,000	145,000	52.63
2012-11-19	2012-11-15	4	CPRX	CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock, par value $0.001 per share	P - Purchase		24,000	24,000		0.41	9,857	9,857
2012-11-13	2012-11-09	4	MEDW	MEDIWARE INFORMATION SYSTEMS INC Common Stock	D - Sale to Issuer		-1,014	0	-100.00	22.00	-22,308
2012-05-09	2012-05-07	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (right to buy)	A - Award		75,000	75,000
2012-05-09	2012-05-07	4	AMPE	Ampio Pharmaceuticals, Inc. Stock Option (right to buy)	A - Award		100,000	100,000
2012-02-13	2012-02-09	4	MEDW	MEDIWARE INFORMATION SYSTEMS INC Common Stock, par value $.10	S - Sale		-7,380	1,014	-87.92	13.55	-99,999	13,740
2012-01-17	2012-01-13	4	AMPE	Ampio Pharmaceuticals, Inc. Common Stock	A - Award		2,268	36,813	6.57	4.41	10,002	162,345
2012-01-04	2012-01-03	4	MEDW	MEDIWARE INFORMATION SYSTEMS INC Common Stock, par value $.10	A - Award		785	8,394	10.32
2011-09-27		3	AMPE	Ampio Pharmaceuticals, Inc. Common Stock				4,545